Kanun da ake yawan gani ya ƙunshi kuskure
A sauƙaƙe za a iya cewa NMN "yana kare zuciya daga ƙarancin oxygen." Wannan ba abin da sabon binciken berayen ya gano ba. Sakamakon ya fi rikitarwa, kuma ya fi ban sha'awa.
A cikin takardar da aka buga a 2026 a Nutrients, masana sun gwada ko nicotinamide mononucleotide (NMN), wani mashahurin mai ba da NAD+, zai iya rage lahani da intermittent normobaric hypoxia ke haifarwa. Wannan yanayi ne na ƙarancin oxygen na lokaci‑lokaci da ke ɗan kama da sleep apnea ko horon da ake yi a tsaunuka. NMN bai hana girman zuciya (cardiac hypertrophy) ba, amma ya rage alamomin damuwar zuciya guda biyu, ya daidaita ma’aunin alwara zuwa kusan daidaito, kuma ya canza ƙwayoyin halittar hanji. A gefe guda, ya ƙara matakin alamar lalata jini, LDH, a serum.
- PubMed: PMID 42942905
- DOI: 10.3390/nu18203334
- Marubuta: Wang Z, Wang M, Guo J, Wang Y, Wang S, Yuan J, Yang R, Bi Y, Ke Y.
Muhimmanci: wannan bincike an yi shi ne a dabbobi kawai, kuma marubutan kansu sun bayyana sakamakon a matsayin bincike na farko.
Menene masu bincike suka yi?
An raba berayen bazuwar zuwa rukuni uku:
- Normoxia – yanayin iskar oxygen na al'ada (rukuni na kulawa).
- Intermittent normobaric hypoxia – ƙananan matakin oxygen a kai‑kai a cikin yanayin matsa lamba daidai.
- Hypoxia da NMN – irin wannan ƙarancin oxygen amma tare da ba da NMN.
Kungiyar ta auna nauyin jiki, nauyin zuciya, gwaje‑gwajen jini, ƙididdigar ƙwayoyin halitta, da ƙwayoyin halittar hanji ta hanyar 16S rRNA gene amplicon sequencing.
Takaitaccen bayanin da aka bayar ba ya ƙunshe da ƙimar NMN, hanyar bayarwa, tsawon lokacin shan, ko adadin dabbobin da aka yi amfani da su. Don haka dole ne a duba cikakken takarda kafin a yanke hukunci kan yadda gwajin ya gudana.
Abin da hypoxia ya haifar wa berayen
Karancin oxygen na lokaci‑kai ya haifar da mummunan lahani. Idan aka kwatanta da normoxia, ya ƙara sosai:
- Nauyin zuciya da girman ventricles
- Nauyin dama na ventricular da ƙididdigarsa
- Ma’aunin alwara
- Aikin lactate dehydrogenase (LDH) a serum – alamar damuwa ko rauni a ƙwayoyin
- Bayyanar BNP da Myh7 a zuciya
Masu rubutu sun fassara wannan a matsayin cardiac hypertrophy mai cutarwa tare da amsa damuwar ventricular. BNP sanannen alamar damuwar zuciya ne, Myh7 kuma yana ɗauke da nau'in myosin da ake kunnawa idan zuciya na fama da matsanancin damuwa. Hypoxia kuma ya rage beta‑diversity na ƙwayoyin halittar hanji kuma ya sauya tsarin su.
Inda NMN ya kasa
A matakin ƙwayoyin, sakamakon ba su da tasiri sosai. NMN bai yi tasiri mai mahimmanci kan mafi yawan ma’aunin ƙwayoyin ko na jini ba, don haka zuciyoyin da suka girma sun ci gaba da haka. Haka kuma, NMN ya haifar da ƙaruwa a aikin serum LDH. Takaitaccen bayanin ba ya fayyace dalilin haka, amma ƙaruwa a alamar lalata ba alamar kariya ba ce, kuma ya kamata a bincika a gaba.
Masu rubutu sun kammala cewa NMN baya hana cardiac hypertrophy da intermittent hypoxia ke haifarwa a matakin ƙwayoyin.
Abin da NMN ya yi da kyau
A yanayin hypoxia, NMN:
- Ya rage bayyanar BNP da Myh7 a ventrikel ɗin dama da hypoxia ta haifar. Alamar damuwar ƙwayoyin ta ragu ko da yake zuciya ta ci gaba da girma.
- Ya mayar da ma’aunin alwara da ƙididdigar alwara zuwa kusan daidaito.
- Ya canza tsarin ƙwayoyin halittar hanji. Takaitaccen bayanin ba ya cewa NMN ya mayar da microbiome zuwa asalin sa, sai kawai ya canza shi.
Masu rubutu sun bayyana wannan a matsayin "tasirin kwayoyin da tsarin jiki na musamman a ƙarƙashin hypoxia, maimakon kariya gaba ɗaya."
Yadda za a fassara wannan sakamako
Rage alamar BNP ko Myh7 na iya zama alama mai kyau, amma ba lallai ne ya nufin zuciya ta fi lafiya ba. A wannan gwaji, girman zuciya (hypertrophy) ya ci gaba da wanzuwa. Alamar na iya motsawa ba tare da canjin sakamako ba, kuma idan alamar rauni (LDH) tana ƙaruwa, hoton gaba ɗaya ba a bayyana ba. Alamomin damuwar ƙwayoyin berayen ba su da tabbacin zama masu hasashen fa'ida ga mutane.
Sakamakon alwara da canjin microbiome suna da ban sha'awa. Alwara na da alaƙa da sarrafa ƙwayoyin jini da amsoshin garkuwar jiki, kuma duka na iya canzawa a ƙarƙashin hypoxia. Microbiome na hanji ana nazari a matsayin hanyar da hypoxia ke shafar dukan jiki. Amma wannan binciken yana ba da alaƙa ne kawai, ba ya nuna canjin microbiome ya haifar da wani fa'ida ba.
Abubuwan da za a ɗauka a aikace
Kudade da lokaci: wannan bincike ba ya ba da shawarar adadin kudade ko lokutan amfani ga mutane. Takaitaccen bayanin ba ya ba da farashin beraye, kuma farashin dabbobi ba su daidaita kai tsaye da na mutane. Kada ku yi amfani da wannan takarda don zaɓar ƙima.
Waɗanda za su iya sha'awa: masana kimiyyar NAD+, likitoci, da masu sha'awar yadda ƙarin magani ke hulɗa da damuwar oxygen. Sha'awa ba ta nufin ya zama dalilin ɗaukar shi ba.
Waɗanda ya kamata su yi hankali ko su guje shi:
- Mutanen da ke da sleep apnea ko cutar zuciya kada su ɗauki NMN a matsayin madadin CPAP, magani, ko kulawar kardiology. Wannan binciken ya nuna babu kariya ga cardiac hypertrophy, kuma berayen ba su da sleep apnea – sun fuskanci yanayin hypoxia ne kawai.
- ‘Yan wasa da ke horo a tsaunuka ba su da hujja a nan na inganta aiki, daidaituwa, ko kariya. Binciken bai auna waɗannan ba.
- Kowa da ke da cutar zuciya, jini, alwara, ko ke shan magunguna ya kamata ya tattauna da likita kafin ya fara amfani da kowanne ƙarin magani.
Iyakokin da ya kamata a tuna
- Dabbobi kawai: an yi aikin a beraye, ba a mutane ba.
- Binciken farko: marubuta sun bayyana hakan kai tsaye kuma sun kira ƙarin bincike.
- Iyakokin samfurin: intermittent normobaric hypoxia a beraye na kusan kama, amma ba daidai yake ba da sleep apnea na ɗan adam ko zaman a tsaunuka.
- Alamomi masu rikitarwa: NMN ya rage wasu alamomi amma ya ƙara LDH kuma ya bar girman zuciya ba tare da canji ba.
- Bayanan da suka ɓace: ƙimar NMN, tsawon lokaci, da yawan dabbobi ba su bayyana a takaitaccen bayanin ba.
Kammalawa
Wannan bincike yana ba da ƙwaƙwalwar tunani ga masu sha'awar NAD+. A berayen da aka sanya su a ƙarƙashin intermittent low oxygen, NMN bai dakatar da zuciya daga girma ba. Ya rage BNP da Myh7, ya daidaita ma’aunin alwara, kuma ya canza microbiome na hanji. Masu rubutu sun ƙara haske ga tasirin zaɓi maimakon kariya gaba ɗaya. Ga mutane, amsar gaskiya ita ce har yanzu ba mu san ko waɗannan canje‑canje suna da tasiri a jikin ɗan adam ba. Za a buƙaci gwaje‑gwajen mutane da sakamako masu ma'ana kafin a yanke shawara.
Wannan labarin na nufin ba da bayani kawai, ba shawara ta likita ba.